packageSatranidazole

satranidazole

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Satranidazole is a nitroimidazole antiprotozoal agent developed for the treatment of protozoal infections such as amoebiasis. It remains an experimental drug and does not appear to have an established, widely authorised place in therapy.

Summary written by glm-5.3-flash from Wikidata Q27260233 and the WHO ATC classification; not checked by a person.

name:satranidazole
ATC codes:P01AB08
DrugBank:DB19950
PubChem CID:41841
Wikidata:Q27260233
formula:C8H11N5O5S
molar mass:289.266 g/mol (PubChem CID 41841)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown